Hughes Steven George sold RNA
August 13, 2025 · Form 4 insider transaction
Hughes Steven George sold 1,542 shares of Atrium Therapeutics, Inc. at $46.66 per share, a transaction worth $71.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,542
Price
$46.66
Total value
$71.9K
InsiderHughes Steven George
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2025
Filing dateAugust 15, 2025
Shares owned after38,867
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.